Sign in

Luc Bellet

Executive Vice President and Chief Financial Officer at CLOROX CO /DE/CLOROX CO /DE/
Executive

About Luc Bellet

Luc Bellet is Executive Vice President and Chief Financial Officer of The Clorox Company, appointed effective April 1, 2025, after 18 years across treasury, FP&A, internal audit, Global Product Supply, and business unit finance roles at Clorox . He is 47 years old and was first appointed an executive officer in 2025 . Company performance context during his tenure includes fiscal year 2025 net sales of $7.1 billion and incentive frameworks tied to economic profit and short-term sales, earnings, and margin outcomes . Clorox’s FY25 annual incentive company multiplier was 80%, and PSUs covering FY23–FY25 paid out at 133% based on economic profit performance, framing the pay-for-performance environment for the CFO’s incentives .

Past Roles

OrganizationRoleYearsStrategic Impact
The Clorox CompanyEVP & Chief Financial Officer2025–presentFinance leadership during ERP transition, margin initiatives, and digital transformation
The Clorox CompanyVice President – TreasurerOct 2023–Apr 2025Treasury oversight and capital structure stewardship
The Clorox CompanyVice President – Financial Planning & AnalysisApr 2018–Oct 2023Enterprise FP&A leading planning, forecasting, and performance analytics
The Clorox CompanyFinance leadership roles (internal audit, Global Product Supply, business units)2006–2018Controls, supply chain finance, and BU execution support

Fixed Compensation

ComponentFY2025 Amount/TermNotes
Base salary (annualized as of 6/30/25)$725,000 Increased upon CFO appointment effective 4/1/25
Target bonus (AIP)100% of salary Target set by MDCC at CFO appointment
Actual AIP payout (FY25)$362,301 Prorated for promotion effective 4/1/25
Perquisites (FY25 total)$37,030 Executive auto $13,200; Financial planning $18,970; Paid parking $3,420; Executive health $1,440

Performance Compensation

FY2025 Annual Incentive Plan (AIP) Metrics and Outcome

MetricWeightThreshold (0%)Target (100%)Maximum (200%)Actual (ex-items)Metric payoutCompany multiplier
Net Customer Sales ($mm)50% $6,721 $7,075 $7,252 $6,870 47% 80%
Net Earnings Attributable to Clorox ($mm)30% $571 $635 $711 $650 103% 80%
Gross Margin (%)20% 42.0% 44.0% 46.0% 44.7% 126% 80%

Notes: AIP actuals exclude specified ERP, cyberattack insurance, divestiture, digital transformation, FX, and equity comp budgeting impacts .

Long-Term Incentive (LTI) Awards – Grants, Structure, and Vesting

Grant dateInstrumentTarget sharesGrant-date fair value ($)Vesting termsPerformance metric
9/17/2024PSUs2,185 $359,848 3-year performance period (FY25–FY27); payout 0–200% Economic Profit (EP) growth
9/17/2024RSUs1,457 $239,953 25% vest on each of first four anniversaries; Oct 5 cadence Time-based
4/1/2025 (promotion)PSUs4,056 $599,923 3-year performance period (FY25–FY27); payout 0–200% EP growth
4/1/2025 (promotion)RSUs2,704 $399,949 25% vest on each of first four anniversaries from grant date Time-based

Program design: NEO LTI mix at grant is 60% PSUs and 40% RSUs; PSU metric is EP growth with annual funding averaged across the 3-year period; RSUs align with stock price and retain talent .

Equity Ownership & Alignment

ItemDetail
Total beneficial ownership39,901 shares; “Percent of Class” indicated as “*” (<1%)
Shares outstanding121,683,474 as of Aug 31, 2025
Right to acquire within 60 days6,358 shares (options/units vesting within 60 days)
Unvested RSUs (tranches)211; 479; 1,155; 1,493; 2,728 units
Unearned PSUs (targets)2,556; 2,304; 2,239; 4,092 units
Stock options outstandingExercisable: 710 @ $135.57; 5,175 @ $151.85; 10,927 @ $155.54; 4,039 @ $212.38; Unexercisable: 1,403 @ $163.77; 2,318 @ $141.30
Ownership guideline3x base salary for NEOs; status as of 9/10/25: Not met for Bellet (recently elevated from 2x to 3x upon CFO appointment)
Retention requirementMust retain 75% of net shares acquired after tax until meeting guideline
Hedging/pledgingProhibited for directors and officers; options trading and derivatives are prohibited

Employment Terms

  • Appointment: EVP & CFO effective April 1, 2025; base salary increased to $725,000; AIP target increased from 50% to 100%; off-cycle RSUs $400,000 and PSUs $600,000 granted on 4/1/25 with 3-year PSU performance ending 6/30/27 .
  • Severance Plan: If terminated without cause (non-CIC), CFO eligible for 2x base salary and prorated AIP; non-solicit for 2 years is required for benefits .
  • Change in Control (CIC) Plan: CFO eligible for 2x base salary plus 2x target AIP upon qualifying termination in connection with a CIC; equity acceleration/vesting per award terms; excise tax cutback applies .
  • Clawbacks: Amended in FY24 to comply with SEC/NYSE; “no-fault” restatement clawback for Section 16 officers; detrimental conduct clawback up to 3 years post-vesting; clawbacks also embedded in AIP and LTI agreements for misconduct .

Potential Payments Upon Termination (as of 6/30/25; $120.07 stock price assumption)

ScenarioCash paymentStock optionsRSUsPSUsHealth & welfareFinancial planningTotal estimated value
Involuntary termination (without cause)$1,993,750 $0 $0 $0 $43,525 $0 $2,037,275
Involuntary termination after CIC$3,625,000 $0 $728,345 $1,267,579 $43,525 $18,970 $5,683,419
Disability or death$0 $75,508 $728,345 $1,267,579 $43,525 $0 $2,071,432

Deferred Compensation

ItemFY2025 AmountAggregate balance
Executive contributions (salary/AIP deferrals)$37,710 $721,427
Registrant contributions (NQDC/Exec Retirement Plan)$72,622
Aggregate earnings in last FY$39,566

Plan features: Voluntary deferrals up to 50% of base and 100% of AIP; 401(k) restoration above IRS limits; distribution elections include lump sum or up to 15 annual installments; balances are unsecured obligations of Clorox .

Performance Compensation – PSU Outcome Context

PSU performance periodEP performancePayout
FY2023–FY2025 (granted Sep 2022)FY23 EP absolute above max; FY24 EP growth above max; FY25 EP growth below threshold (adjusted for specified events); average payout 133% 133%

Investment Implications

  • Alignment and retention: Bellet’s package is heavily performance-based (PSUs + AIP tied to EP, sales, earnings, margin) with recent off-cycle awards at promotion; ownership guideline not yet met suggests continued net share retention until compliance, reducing near-term sell pressure from exercises/vestings .
  • Selling pressure and vesting: Multiple RSU tranches and PSU cycles create scheduled vesting events; insider hedging/pledging is prohibited, and trades require preclearance or approved plans, mitigating adverse signaling risk from opportunistic sales .
  • Downside/CIC protections: Severance and CIC economics are moderate (2x base and 2x AIP for CIC), balancing retention versus shareholder dilution; clawbacks provide recourse on restatements or detrimental conduct, limiting governance risk .
  • Performance linkage: Company’s FY25 AIP result at 80% and recent PSU payout at 133% frame incentive sensitivity; FY2026 outlook reiterations place emphasis on navigating ERP shipment reversal and margin headwinds—key levers under CFO oversight for economic profit delivery .